PlumX Metrics
Embed PlumX Metrics

Premature ejaculation: Diagnosis and pharmacotherapy

International Journal of Pharmaceutical Medicine, ISSN: 1364-9027, Vol: 14, Issue: 6, Page: 313-318
2000
  • 8
    Citations
  • 0
    Usage
  • 7
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Premature ejaculation (PE) is extremely common, affecting around one-quarter of all men. Men readily recognize their PE but rarely report this to their doctors. When they do the mainstay of treatment has been behavioural therapy, which usually requires the cooperation of sexual partners. This can be effective but relapses are common. No pharmacological agents are approved for use in PE, although some, including anti-depressants, are used off-label. Clinical trials have been completed which show that pharmacological agents are effective in prolonging latency to ejaculation. However, diagnostic criteria vary and only limited attempts have been made to operationalize the definition of PE. A validated symptom-based questionnaire is not available and so end-points have for the main relied on measurements of latency to ejaculation. Whether and how these equate to measures of sexual satisfaction has not been determined.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know